Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Nuclear acids in human blood plasma.C R Seances Soc Biol Fil. 1948; 142 (Les acides nucleiques du plasma sanguin chez l'homme): 241-243
- Life and death of circulating cell-free DNA.Cancer Biol Ther. 2019; 20: 1057-1067
- Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res. 1977; 37: 646-650
- Isolation and characterization of DNA from the plasma of cancer patients.Eur J Cancer Clin Oncol. 1987; 23: 707-712
- Soluble normal and mutated DNA sequences from single-copy genes in human blood.Cancer Epidemiol Biomarkers Prev. 1994; 3: 67-71
- A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications.Genes Chromosomes Cancer. 2018; 57: 123-139
- Validating cell-free DNA from supernatant for molecular diagnostics on cytology specimens.Cancer Cytopathol. 2021; 129: 956-965
- Beyond the blood: CSF-derived cfDNA for diagnosis and characterization of CNS tumors.Front Cell Dev Biol. 2020; 8: 45
- Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling.Mod Pathol. 2018; 31: 1036-1045
- Circulating tumor DNA analysis in patients with cancer: american society of clinical oncology and college of american pathologists joint review.J Clin Oncol. 2018; 36: 1631-1641
- The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF Italian Scientific Societies.ESMO Open. 2021; 6: 100164
- Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.Pancreas. 1998; 17: 89-97
- Liquid biopsies come of age: towards implementation of circulating tumour DNA.Nat Rev Cancer. 2017; 17: 223-238
- Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin.Cell. 2016; 164: 57-68
- Enhanced detection of circulating tumor DNA by fragment size analysis.Sci Transl Med. 2018; 10: eaat4921
- Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model.Clin Chem. 2012; 58: 549-558
- Next-generation sequencing of cell-free DNA extracted from pleural effusion supernatant: applications and challenges.Front Med (Lausanne). 2021; 8: 662312
- Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.Int J Med Sci. 2021; 18: 1510-1518
- Technical and methodological aspects of cell-free nucleic acids analyzes.Int J Mol Sci. 2020; 21: 8634
- Urine as a source of liquid biopsy for cancer.Cancers (Basel). 2021; 13: 2652
- Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.Mol Aspects. 2020; 72: 100828
- Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations.Proc Natl Acad Sci U S A. 2003; 100: 8817-8822
- The opportunities and challenges of molecular tagging next-generation sequencing in liquid biopsy.Mol Diagn Ther. 2021; 25: 537-547
- Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.Cancer Res. 2012; 72: 3492-3498
- Integrated digital error suppression for improved detection of circulating tumor DNA.Nat Biotechnol. 2016; 34: 547-555
- Detection and diagnostic utilization of cellular and cell-free tumor DNA.Annu Rev Pathol. 2021; 16: 199-222
- Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid.Clin Cancer Res. 2018; 24: 2812-2819
- Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.Acta Neuropathol. 2019; 137: 297-306
- Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.Cancer Cell. 2021; 39: 1519-1530.e4
- Screening system for epidermal growth factor receptor mutation detection in cytology cell-free DNA of cerebrospinal fluid based on assured sample quality.Cytopathology. 2019; 30: 144-149
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.Ann Oncol. 2018; 29: 945-952
- Early detection of leptomeningeal metastasis by PCR examination of tumor-derived K-ras DNA in cerebrospinal fluid.Clin Chem. 2000; 46: 132-133
- Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.BMC Neurol. 2019; 19: 331
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.Sci Transl Med. 2015; 7: 293ra104
- Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas.Am J Surg. 1994; 168: 429-432
- Molecular sputum analysis for the diagnosis of lung cancer.Br J Cancer. 2013; 109: 530-537
- Sputum cell-free DNA: valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.Cancer Med. 2021; 10: 3323-3331
- EGFR mutation status yield from bronchoalveolar lavage in patients with primary pulmonary adenocarcinoma compared to a venous blood sample and tissue biopsy.PeerJ. 2021; 9: e11448
- Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.Clin Chem Lab Med. 2017; 55: 1489-1495
- Feasibility of bronchial washing fluid-based approach to early-stage lung cancer diagnosis.Oncologist. 2019; 24: e603-e606
- Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.Sci Transl Med. 2013; 5: 167ra4
- Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.Sci Transl Med. 2018; 10: eaap8793
- Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study.PLoS Med. 2016; 13: e1002206
- Lavage of the uterine cavity for molecular detection of mullerian duct carcinomas: a proof-of-concept study.J Clin Oncol. 2015; 33: 4293-4300
- Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients.Gastroenterology. 2008; 135: 489-498
- Detection of bladder cancer using urinary cell-free DNA and cellular DNA.Clin Transl Med. 2020; 9: 4
- Urinary molecular pathology for patients with newly diagnosed urothelial bladder cancer.J Urol. 2021; 206: 873-884
- Detection and surveillance of bladder cancer using urine tumor DNA.Cancer Discov. 2019; 9: 500-509
- Urine-based liquid biopsy for nonurological cancers.Genet Test Mol Biomarkers. 2019; 23: 277-283
- Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: look closer to the tumor!.Cells. 2020; 9: 2486
Article info
Publication history
Published online: August 22, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
